Rifetech Ltd. presents technology developed with the support of European grant funds in the field of innovation under the auspices of the Ministry of Industry and Trade.
An expert team, under the leadership of doc. Ing. Vladimír Holcman, Ph.D., Ing. Robert Macků, Ph.D., Ing. Tomáš Trčka, Ph.D., from the Institute of Physics, in cooperation with biologist RNDr. Dagmar Jančová, Ph.D., aimed to develop a new methodology that reflects rapidly changing trends in technology and health.
The result of successfully performed simulations, calculations, and modulations of plasma discharge is a device with a highly stable and accurate therapeutic signal, which is designated for experimental research of the effect of electromagnetic waves on human health.
RIFETECH Plasma has the unique ability to elicit a biological response of the organism with a therapeutic effect through an accurate and stable signal. RIFETECH Plasma achieves this by an innovative combination of specific plasma properties and EM field with original frequency protocols acting not only on the whole genomes of pathogenic microorganisms.
As a result, Rifetech Ltd. is becoming a worldwide leader of the emerging discipline of bio-electromagnetic therapy.RIFETECH Plasma functions are clearly divided into 11 complexes: VIRUSES, BACTERIA, PARASITES, MITES, MOLD, DISEASES, STABILIZATION COMPLEXES, IMMUNE SYSTEM, REVITALIZATION, HARMONIZATION, BIOFEEDBACK
|
||||||||
| Dimensions | ||||||||
|---|---|---|---|---|---|---|---|---|
|
||||||||